Are you Dr. Haskell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 29 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Medical 530 420 120 Plz
# 365
Los Angeles, CA 90095Phone+1 310-794-9718- Is this information wrong?
Summary
- Dr. Charles Haskell, MD is an oncologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is a Professor at UCLA School of Medicine.
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1970 - 1971
- University of California (San Francisco)Residency, Internal Medicine, 1965 - 1967
- University of California San Francisco School of MedicineClass of 1965
Certifications & Licensure
- CA State Medical License 1966 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow (FASCO) American Society of Clinical Oncologists, 2010
Publications & Presentations
PubMed
- 33 citationsMultiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated...Malini Harigopal, William E. Barlow, Greg Tedeschi, Peggy L. Porter, I-Tien Yeh, Charles Haskell, Robert B. Livingston, Gabriel N. Hortobagyi, George W. Sledge, Charle...> ;The American Journal of Pathology. 2010 Apr 1
- 53 citationsOutcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function of HER2 and TOP2A StatusRaymond R. Tubbs, William E. Barlow, G. Thomas Budd, Eric Swain, Peggy L. Porter, Allen M. Gown, I-Ten Yeh, George W. Sledge, Charles Shapiro, James N. Ingle, Charles ...> ;Journal of Clinical Oncology. 2009 Aug 20
- 34 citationsSequenced Compared With Simultaneous Anthracycline and Cyclophosphamide in High-Risk Stage I and II Breast Cancer: Final Analysis From INT-0137 (S9313)Hannah M. Linden, Charles M. Haskell, Stephanie Green, C. Kent Osborne, George W. Sledge, Charles L. Shapiro, James N. Ingle, Danika Lew, Laura F. Hutchins, Robert B. ...> ;Journal of Clinical Oncology. 2007 Feb 9
- Join now to see all
Press Mentions
- Charles M. Haskell, MD, Presented with the Albert Nelson Marquis Lifetime Achievement Award by Marquis Who's WhoMarch 12th, 2019
Professional Memberships
- Fellow